Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003365 · ClinicalTrials.gov registry record · NA
Sulindac and Plant Compounds in Preventing Colon Cancer
A NA study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
NCT00003365 is a NA study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey.
The verdict
NCT00003365, a NA study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of sulindac may be an effective way to prevent colon cancer. Eating a diet rich in fruits and vegetables appears to reduce the risk of some types of cancer. Curcumin, rutin, and quercetin are compounds found in plants that may prevent the development of colon cancer. PURPOSE: Randomized clinical trial to study the effectiveness of sulindac, curcumin, rutin, and quercetin in preventing colon cancer.
Interventions
- DIETARY_SUPPLEMENT curcumin
- DRUG quercetin
- DRUG sulindac
- DIETARY_SUPPLEMENT rutin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-08 |
| Est. Completion | 2006-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003365
The ClinicalTrials.gov registry entry for NCT00003365 describes a study currently listed as terminated, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which curcumin is the first listed.
NCT00003365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003365 about?
NCT00003365 is a clinical study titled "Sulindac and Plant Compounds in Preventing Colon Cancer". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of sulindac may be an effective way to prevent colon cancer. Eating a diet rich in fruits and vegetables appears to reduce the risk of some types of cancer. Curcumin, rut...
What is the current status of trial NCT00003365?
This trial is currently terminated. It is a NA study. The study started on 1996-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00003365?
The interventions under investigation include: curcumin (DIETARY_SUPPLEMENT), quercetin (DRUG), sulindac (DRUG), rutin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00003365?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.